Showing results (51-60 of 253) with videos related to
Sort By:
Pageof 26
Mathematical Biosciences|January 8, 2024
A stochastic framework for evaluating CAR T cell therapy efficacy and variabilityChau Hoang, Tuan Anh Phan, Cameron J Turtle, et al.Chimerism|February 18, 2011
Double unit cord blood transplantation: Who wins-and why do we care?Jonathan A Gutman, Stanley R Riddell, Suzanne McGoldrick, et al.International Journal of Hematology|November 15, 2002
Minor histocompatibility antigens--targets of graft versus leukemia responsesStanley R Riddell, M Murata, S Bryant, et al.Current Opinion in Immunology|September 27, 2021
Synthetic receptors for logic gated T cell recognition and functionSylvain Simon, Grace Bugos, Alex I Salter, et al.Expert Review of Hematology|November 19, 2010
Adoptive T-cell therapy for B-cell malignanciesMichael Hudecek, Larry D Anderson, Tetsuya Nishida, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 20, 2002
T-cell therapy of leukemiaStanley R Riddell, Makoto Murata, Sophia Bryant, et al.Cancer Research|July 5, 2006
Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1Wei Wang, Jennifer Epler, Lupe G Salazar, et al.Blood|September 20, 2017
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapyKevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, et al.Blood Advances|November 20, 2019
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapyJoshua A Hill, Elizabeth M Krantz, Kevin A Hay, et al.Haematologica|July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphomaValentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.Pageof 26